Similar articles

• Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.

  Drüeke TB, Bárány P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougall IC, Pippard MJ, Shaldon S, van Wyck D. Drüeke TB, et al. Clin Nephrol. 1997 Jul;48(1):1-8. Clin Nephrol. 1997. PMID: 9247771 Review.
• [Stability of hemoglobin levels: an indispensible paradigm change in medical management].

  Zaoui P, Deray G, Ortiz JP, Rostaing L. Zaoui P, et al. Nephrol Ther. 2011 Feb;7(1 Suppl 2):H5-7. doi: 10.1016/S1769-7255(11)70002-5. Nephrol Ther. 2011. PMID: 21371678 Review. French. No abstract available.
• Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.

  Kotaki M, Uday K, Henriquez M, Blum S, Dave M. Kotaki M, et al. Clin Nephrol. 1997 Jul;48(1):63-4. Clin Nephrol. 1997. PMID: 9247787 Clinical Trial. No abstract available.
• Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.

  Fishbane S. Fishbane S. Semin Dial. 2008 May-Jun;21(3):217-20. doi: 10.1111/j.1525-139X.2007.00420.x. Epub 2008 Feb 1. Semin Dial. 2008. PMID: 18248518 Review.
• Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond.

  Mittman N. Mittman N. Am J Kidney Dis. 1999 Jul;34(1):173-6. doi: 10.1016/s0272-6386(99)70127-7. Am J Kidney Dis. 1999. PMID: 10401035 No abstract available.